113 results
Page 3 of 6
8-K
EX-99.1
nhp5a llcalv
10 Nov 21
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-1.1
903hraom1pwm t2tjx
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
ttrzz0
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K/A
k84vrrwswd zbjo
16 Jun 21
Submission of Matters to a Vote of Security Holders
6:05am
8-K
EX-99.1
l0z7jax37
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
2o4ulj56
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
rqo0ple2zdqf1fvb4g20
11 Dec 20
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
8:31am
8-K
EX-99.1
rzusp3dbuw3gridol
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
EX-99.1
xa3g5rgxs 1nt2qa0l6
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
8-K
EX-1.1
5ek3ctv96o phxk7f9d
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
cmw4be wshmiibun5vb
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
x92fxxmskm5ss2n6
23 Jun 20
Prospectus supplement for primary offering
4:06pm